]>
IRCT20250608066122N1 IRCT 2025-06-27 Ahvaz University of Medical Sciences Effect of black garlic on patients with non-alcoholic fatty liver disease Effect of black garlic and garlic supplementation on cardiometabolic risk factors and fibroscan findings in patients with non-alcoholic fatty liver disease: a double-blind randomized controlled clinical trial 2025-07-23 anticipated 93 Complete https://irct.ir/trial/84178 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: After selecting the study subjects, the subjects will be divided into three groups: garlic, black garlic, and placebo (n = 1 in each group) in a 1:1 ratio using the block method. The blocks of six were created by the statistical software Random Allocation Software (RAS) and will be identified with the letters A, B, and C, Blinding description: Since participants do not know which group they are in, their beliefs about the treatment do not affect the outcome, and since clinical caregivers do not know which group is actually receiving treatment, they are unable to influence the course of treatment by revealing small clues. N/A Non alcoholic Fatty liver. Intervention 1: Intervention group:black garlic. Intervention 2: Intervention group: garlic. Intervention 3: Control group: placebo. No - There is not a plan to make this available Justification or reason for not sharing IPD is Patient information is private and cannot be published to protect the information.
public Soroor fathi
No. 18 ,2 Ave., beheshti Blvd.,shahin shahr Town
Shahin shahr Iran (Islamic Republic of) 8314895182 +98 31 4522 6525 Soroor.s1705@gmail.com Ahvaz University of Medical Sciences scientific Seyed ahmad hosseini
Golestan ave,ahvaz university medical sience
Ahvaz Iran (Islamic Republic of) 1234567890 +98 61 3311 2537 Seyedahmadhosseini@yahoo.com Ahvaz University of Medical Sciences Iran (Islamic Republic of) Performance to participate in the study Age 20-65 years Body mass index (BMI) 25 and above Performed by ultrasound method 20 years 65 years Female Pregnancy and breastfeedingSmokingIntake of large amounts of garlic in daily food intakeTreatment of heart, lung, kidney diseases, hepatitis, cirrhosis, biliary and immune system disorders, high blood pressure, hypothyroidism, Cushing's syndromeUse of drugs for consumption and blood sugar, vitamins E and D, ursodeoxycholic acid, phenytoin, tamoxifen, lithium, corticosteroids and methotrexateWeight loss and bariatric surgery in the last yearGarlic reviewNo use of other herbal supplements in the last three months K76.0 Fatty (change of) liver, not elsewhere classified Treatment - Other Treatment - Other Placebo Intervention group:black garlic Intervention group: garlic Control group: placebo Monitoring people with fatty liver disease. Timepoint: ٬۰۰۰At the beginning of the study (before starting work) and 12 weeks later. Method of measurement: Fibroscan. Soroor fathi Approved 1994-10-26 Ethics committee of ahvaz University of Medical Sciences No. 18, 2Ave., beheshti Blvd., shahin shahr Town Isfahan Isfehan Iran (Islamic Republic of)